Nyxoah (NYXH) EPS (Weighted Average and Diluted) (2025 - 2026)
Nyxoah's quarterly EPS (Weighted Average and Diluted) came in at $44046.1 in Q1 2026, up 17.66% year-on-year from $37434.8 in Q1 2025, and up 17.66% quarter-over-quarter from $37434.8 in Q1 2025.
Nyxoah has reported EPS (Weighted Average and Diluted) for 2 years, with the latest figure at $44046.1 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 17.66% year-over-year to $44046.1; the trailing twelve-month figure through Mar 2026 stood at $44046.1 (up 17.66% YoY), and the FY2025 full-year result was -$2.75, down 42.35% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at $44046.1, up from $37434.8 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $44046.1 in Q1 2026, with the low at $37434.8 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 2.28 |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -1.11 |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 2.74 |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 1.92 |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 0.07 |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 0.66 |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 1.57 |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -0.03 |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 1.12 |
| 10 | Nyxoah | 1,248.49 | 1,248.49 | 4.26 Mn | 44,046.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44,046.07 |
| Mar 31, 2025 | 37,434.78 |